This list is an analysis based on recent market events. It's not an investment recommendation.
About
Abera Bioscience AB, a platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally. The company's development platform named BERA, uses for the display of antigens at the surface of outer membrane vesicles derived from genetically optimized gram-negative bacteria. Its lead vaccine candidate is a universal pneumococcal vaccine based on the platform BERA. The company also develops projects in immuno-oncology, Chlamydia, ETEC, Covid-19, and Tuberculosis. The company was incorporated in 2012 and is based in Uppsala, Sweden.
The current price of ABERA.ST is SEK6.86 SEK — it has increased by +1.48% in the past 24 hours. Watch Abera Bioscience AB stock price performance more closely on the chart.
What is Abera Bioscience AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Stockholm Exchange exchange Abera Bioscience AB stocks are traded under the ticker ABERA.ST.
What is Abera Bioscience AB market cap?▼
Today Abera Bioscience AB has the market capitalization of 140.62M
What is Abera Bioscience AB revenue for the last year?▼
Abera Bioscience AB revenue for the last year amounts to 0 SEK.
What is Abera Bioscience AB net income for the last year?▼
ABERA.ST net income for the last year is -10.45M SEK.
How many employees does Abera Bioscience AB have?▼
As of November 2, 2026, the company has 5 employees.
In which sector is Abera Bioscience AB located?▼
Abera Bioscience AB operates in the Health & Wellness sector.
When did Abera Bioscience AB complete a stock split?▼
Abera Bioscience AB has not had any recent stock splits.
Where is Abera Bioscience AB headquartered?▼
Abera Bioscience AB is headquartered in Uppsala, Sweden.